Membranoproliferative glomerulonephritis history and symptoms: Difference between revisions
(Created page with "__NOTOC__ {{Membranoproliferative glomerulonephritis}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Disease Category:Nephrology") |
|||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==History and Symptoms== | |||
* Patients with MPGN may present in 1 of 5 ways, as follows: | |||
:* Asymptomatic proteinuria and hematuria detected on routine urinalysis (23-30%) | |||
:* Nephrotic syndrome (42-67%) | |||
:* Acute nephritic syndrome (16-30%) | |||
:* Recurrent episodes of gross hematuria (10-20%) | |||
:* Azotemia | |||
* Asymptomatic presentation: Proteinuria and hematuria may be detected on routine urinalysis, prompting further investigations. | |||
* Gross hematuria: Patients may have episodes of gross hematuria similar to those observed with immunoglobulin A (IgA) nephropathy. These episodes are usually associated with upper respiratory infection. | |||
* Edema: Periorbital or dependent edema may develop in patients with nephritic or nephrotic presentations. | |||
* Fatigue: This symptom is secondary to anemia or azotemia. The anemia often is disproportional to the degree of renal insufficiency and relates to complement-mediated lysis of red cells. | |||
* Oliguria: Patients with an acute nephritic presentation may develop a decrease in urine output. | |||
* Azotemic symptoms: Patients may develop acute renal failure with the acute nephritic syndrome, which usually correlates with crescentic transformation on histology. Other patients may present with advanced chronic renal insufficiency. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 16:24, 28 September 2012
Membranoproliferative glomerulonephritis Microchapters |
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Membranoproliferative glomerulonephritis history and symptoms On the Web |
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis history and symptoms |
FDA on Membranoproliferative glomerulonephritis history and symptoms |
CDC on Membranoproliferative glomerulonephritis history and symptoms |
Membranoproliferative glomerulonephritis history and symptoms in the news |
Blogs on Membranoproliferative glomerulonephritis history and symptoms |
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
Risk calculators and risk factors for Membranoproliferative glomerulonephritis history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
History and Symptoms
- Patients with MPGN may present in 1 of 5 ways, as follows:
- Asymptomatic proteinuria and hematuria detected on routine urinalysis (23-30%)
- Nephrotic syndrome (42-67%)
- Acute nephritic syndrome (16-30%)
- Recurrent episodes of gross hematuria (10-20%)
- Azotemia
- Asymptomatic presentation: Proteinuria and hematuria may be detected on routine urinalysis, prompting further investigations.
- Gross hematuria: Patients may have episodes of gross hematuria similar to those observed with immunoglobulin A (IgA) nephropathy. These episodes are usually associated with upper respiratory infection.
- Edema: Periorbital or dependent edema may develop in patients with nephritic or nephrotic presentations.
- Fatigue: This symptom is secondary to anemia or azotemia. The anemia often is disproportional to the degree of renal insufficiency and relates to complement-mediated lysis of red cells.
- Oliguria: Patients with an acute nephritic presentation may develop a decrease in urine output.
- Azotemic symptoms: Patients may develop acute renal failure with the acute nephritic syndrome, which usually correlates with crescentic transformation on histology. Other patients may present with advanced chronic renal insufficiency.